Lsa Pharmacy Inc
Lsa Pharmacy Inc shows consistent revenue growth and healthy asset accumulation with no reported officer compensation.
EIN: 201457251 · Salisbury, NC · Updated: 2026-03-28
Is Lsa Pharmacy Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Lsa Pharmacy Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Lsa Pharmacy Inc
Lsa Pharmacy Inc (EIN: 201457251) is a nonprofit organization based in Salisbury, NC. The organization reported total revenue of $10.8M and total assets of $16.2M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Lsa Pharmacy Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Lsa Pharmacy Inc is a large nonprofit that has been operating for 38 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 4.4%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $9.0M |
| Total Expenses | $8.3M |
| Surplus / Deficit | +$621K |
| Total Assets | $14.2M |
| Total Liabilities | $365K |
| Net Assets | $13.8M |
| Operating Margin | 6.9% |
| Debt-to-Asset Ratio | 2.6% |
| Months of Reserves | 20.4 months |
Financial Health Grade: A
In 2023, Lsa Pharmacy Inc reported a surplus of $621K with revenue exceeding expenses, holds 20.4 months of operating reserves (strong position), has a debt-to-asset ratio of 2.6% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Lsa Pharmacy Inc's revenue has grown at a compound annual growth rate (CAGR) of 4.4%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +11.6% | +12.9% | +7.5% |
| 2022 | +6.6% | +4.8% | +0.8% |
| 2021 | -6.6% | -0.2% | +6.6% |
| 2020 | -1.9% | -3.6% | +8.9% |
| 2019 | +0.7% | +2.4% | +9.1% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 7000 |
| IRS Ruling Date | 1988 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Lsa Pharmacy Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 90%
- fundraising: 0%
According to IRS 990 filings, Lsa Pharmacy Inc allocates its expenses as follows: admin: 10%, programs: 90%, fundraising: 0%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $621K, with revenue exceeding expenses.
- Debt-to-asset ratio: 2.6%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, which is highly unusual for an organization of its size with revenues exceeding $8 million annually. This suggests either a volunteer-led executive team or that executive compensation is categorized differently within the expense structure, warranting further investigation for full transparency.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Lsa Pharmacy Inc's IRS 990 filings:
- Unusually low (0%) reported officer compensation for an organization of this size, which may obscure actual executive remuneration.
- Lack of detailed expense breakdown (program, admin, fundraising) in the provided summary data makes full efficiency assessment difficult.
Strengths
The following positive indicators were identified for Lsa Pharmacy Inc:
- Consistent revenue growth, from $6.5M in 2014 to $8.9M in 2023, indicating financial stability.
- Healthy asset accumulation, growing from $6.3M in 2014 to $14.1M in 2023, suggesting strong financial management.
- Consistent operational surplus, with revenues exceeding expenses in every reported period (e.g., $8,967,538 revenue vs. $8,346,087 expenses in 2023).
- Low liabilities relative to assets, indicating a strong balance sheet (e.g., $364,835 liabilities vs. $14,163,938 assets in 2023).
Frequently Asked Questions about Lsa Pharmacy Inc
Is Lsa Pharmacy Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Lsa Pharmacy Inc (EIN: 201457251) some concerns. Mission Score: 85/100. 2 red flags identified, 4 strengths noted.
How does Lsa Pharmacy Inc spend its money?
Lsa Pharmacy Inc directs 90% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Lsa Pharmacy Inc tax-deductible?
Lsa Pharmacy Inc is registered as a tax-exempt nonprofit (EIN: 201457251). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What is the specific mission of Lsa Pharmacy Inc, given its name and financial activity?
The provided data does not explicitly state the mission, but the name 'Lsa Pharmacy Inc' suggests a focus on pharmaceutical services or support. Further investigation into their 990 forms would clarify their specific programmatic activities.
How does Lsa Pharmacy Inc manage to operate with 0% officer compensation?
The consistent reporting of 0% officer compensation is highly unusual. It could indicate a volunteer-based leadership, or that compensation for key personnel is categorized under other expense lines, such as 'salaries and wages' for non-officer roles, or through related entities. This would require a deeper dive into their detailed 990 forms.
What are the primary program activities funded by Lsa Pharmacy Inc's expenses?
Without a detailed breakdown of expenses beyond total expenses, it's impossible to determine the specific program activities. The name suggests pharmacy-related services, but the exact nature of their programs (e.g., providing medications, pharmacy education, research) is not clear from the summary data.
Filing History
IRS 990 filing history for Lsa Pharmacy Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Lsa Pharmacy Inc's revenue has grown by 68.3%, moving from $5.3M to $9.0M. Total assets increased by 242% over the same period, from $4.1M to $14.2M. Total functional expenses rose by 75%, from $4.8M to $8.3M. In its most recent filing year (2023), Lsa Pharmacy Inc reported a surplus of $621K, with revenue exceeding expenses. The organization holds $365K in liabilities against $14.2M in assets (debt-to-asset ratio: 2.6%), resulting in net assets of $13.8M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $9.0M | $8.3M | $14.2M | $365K | — | View 990 |
| 2022 | $8.0M | $7.4M | $13.2M | $250K | — | View 990 |
| 2021 | $7.5M | $7.1M | $13.1M | $235K | — | View 990 |
| 2020 | $8.1M | $7.1M | $12.3M | $203K | — | — |
| 2019 | $8.2M | $7.3M | $11.3M | $289K | — | View 990 |
| 2018 | $8.2M | $7.2M | $10.3M | $280K | — | View 990 |
| 2017 | $7.9M | $7.0M | $9.2M | $228K | — | View 990 |
| 2016 | $7.4M | $6.6M | $8.2M | $282K | — | View 990 |
| 2015 | $7.3M | $6.4M | $7.3M | $172K | — | View 990 |
| 2014 | $6.6M | $5.7M | $6.4M | $181K | — | View 990 |
| 2013 | $6.1M | $5.2M | $5.7M | $282K | — | View 990 |
| 2012 | $5.8M | $5.1M | $4.7M | $220K | — | View 990 |
| 2011 | $5.3M | $4.8M | $4.1M | $361K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $9.0M, expenses of $8.3M, and assets of $14.2M (revenue +11.6% year-over-year).
- 2022: Revenue of $8.0M, expenses of $7.4M, and assets of $13.2M (revenue +6.6% year-over-year).
- 2021: Revenue of $7.5M, expenses of $7.1M, and assets of $13.1M (revenue -6.6% year-over-year).
- 2020: Revenue of $8.1M, expenses of $7.1M, and assets of $12.3M (revenue -1.9% year-over-year).
- 2019: Revenue of $8.2M, expenses of $7.3M, and assets of $11.3M (revenue +0.7% year-over-year).
- 2018: Revenue of $8.2M, expenses of $7.2M, and assets of $10.3M (revenue +3.3% year-over-year).
- 2017: Revenue of $7.9M, expenses of $7.0M, and assets of $9.2M (revenue +7.1% year-over-year).
- 2016: Revenue of $7.4M, expenses of $6.6M, and assets of $8.2M (revenue +0.9% year-over-year).
- 2015: Revenue of $7.3M, expenses of $6.4M, and assets of $7.3M (revenue +11.6% year-over-year).
- 2014: Revenue of $6.6M, expenses of $5.7M, and assets of $6.4M (revenue +6.6% year-over-year).
- 2013: Revenue of $6.1M, expenses of $5.2M, and assets of $5.7M (revenue +5.7% year-over-year).
- 2012: Revenue of $5.8M, expenses of $5.1M, and assets of $4.7M (revenue +9.1% year-over-year).
- 2011: Revenue of $5.3M, expenses of $4.8M, and assets of $4.1M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Lsa Pharmacy Inc:
Data Sources and Methodology
This transparency report for Lsa Pharmacy Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.